AbbVie Korea has launched XEN 63, a new option for treating glaucoma in patients whose intraocular pressure (IOP) is not ...

The government's financial support for labor and delivery centers in vulnerable areas is not enough to increase the number of ...

An international consensus statement outlining antiplatelet treatment strategies for East Asians has recently been ...

The Ministry of Food and Drug Safety (MFDS) is examining whether to urgently introduce anakinra (Kineret in trademark name), ...

A research team at Seoul National University Bundang Hospital (SNUBH) has developed an artificial intelligence (AI) ...

Vetter, a leading, globally operating contract development and manufacturing organization (CDMO), celebrated the start of ...

Many people think that surgical scars are incurable, but this is not the case.Patients experience skin problems during cancer ...

A Seoul doctor who profited from administering psychotropic drugs to propofol addicts under the guise of cosmetic procedures ...

For a decade, CAR-T therapies such as Bristol Myers Squibb’s Abecma and Breyanzi, Gilead Sciences’ Yescarta and Tecartus, ...

Since the conflict between the medical community and the government began in February 2024, more than 3,000 medical students ...

Samsung Bioepis is handing its newest denosumab copycat, Xbryk, a biosimilar to Amgen’s bone cancer drug Xgeva, to longtime ...

Kuhnil Pharm has named former Takeda Korea General Manager Moon Hee-seok as its new co-CEO.Moon will oversee the company’s ...